Cibus, Inc., an agricultural biotechnology company, announced on January 21, 2025, that it has entered into securities purchase agreements with existing investors, including its CEO, Rory Riggs, to ...
On the basis of the share capital of the Company immediately before completion of the Fundraising, the interest of a shareholder who held 1.00% of the Company's share capital at that time and who did ...
Institutional Investor Exercises Pre-Funded Warrants Acquired as Part of ClearDoc, Inc. Acquisition SEATTLE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (BNZI) (NASDAQ: BNZI) (“Banzai ...
On the basis of the share capital of the Company immediately before completion of the Private Placement, the interest of a shareholder who held 1.00% of the Company’s share capital at that time and ...
The Warrant Amendment Agreement, with respect to Investor Warrants held by Mr. Riggs is conditioned on, and will not be effective until, the trading day after the Company obtains the requisite ...
GameStop warrants trade at a premium to comparable call options, creating a notable pricing inefficiency. Click here to read ...
Veea Inc. (NASDAQ:VEEA) saw its shares fall by 2.4% after the company announced plans to raise capital through a new offering of common stock and warrants, using a “reasonable best efforts” approach.
SeaStar Medical raised approximately $6 million through a registered direct offering, selling shares and warrants to a single investor. SeaStar Medical Holding Corporation announced the successful ...
The Company has also agreed to issue to the Institutional Investor warrants (the “Warrants” and, together with the ADSs, the “Securities”) to purchase up to an aggregate of 361,011 ADSs (representing ...
RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the "Company"), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results